Open Access System for Information Sharing

Login Library

 

Article
Cited 8 time in webofscience Cited 8 time in scopus
Metadata Downloads
Full metadata record
Files in This Item:
There are no files associated with this item.
DC FieldValueLanguage
dc.contributor.authorLee, Eunjin-
dc.contributor.authorKim, Mingyu-
dc.contributor.authorLee, You Jeong-
dc.date.accessioned2023-07-11T04:21:57Z-
dc.date.available2023-07-11T04:21:57Z-
dc.date.created2022-08-21-
dc.date.issued2022-06-
dc.identifier.issn1664-3224-
dc.identifier.urihttps://oasis.postech.ac.kr/handle/2014.oak/117943-
dc.description.abstractCopyright © 2022 Lee, Kim and Lee.Alopecia areata (AA) is an autoimmune disease mediated by NKG2D-expressing cytotoxic T lymphocytes destroying hair follicles in the skin. It is one of the most common autoimmune diseases, but there is no effective treatment modality approved by the FDA. Regulatory T cells (Tregs) are crucial for suppressing autoreactive T cells, and in the skin, they promote hair growth by inducing anagen. Based on this, we tested the therapeutic potential of expanded Tregs in AA using the C3H/HeJ mouse model. In mice with AA, NKG2D-expressing CD8 T cells widely infiltrate both haired and hairless skin areas, which have tissue-resident memory T-cell phenotypes. Tregs in the skin express CD25, CTLA-4, GATA-3, and Jagged1 and efficiently proliferate with IL-2 cytokine antibody complex. However, expanding Tregs in the skin did not induce anagen in normal mice, indicating that they are necessary but not sufficient for anagen induction. Also, they fail to suppress autoreactive CD8 T cells in the skin to reverse established AA in C3H/HeJ mice. These results suggest that Treg expansion alone is not sufficient for AA treatment, and combined immunotherapy is required.-
dc.languageEnglish-
dc.publisherFrontiers Media S.A.-
dc.relation.isPartOfFrontiers in Immunology-
dc.titleSelective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice-
dc.typeArticle-
dc.identifier.doi10.3389/fimmu.2022.874778-
dc.type.rimsART-
dc.identifier.bibliographicCitationFrontiers in Immunology, v.13-
dc.identifier.wosid000884919400001-
dc.citation.titleFrontiers in Immunology-
dc.citation.volume13-
dc.contributor.affiliatedAuthorLee, Eunjin-
dc.contributor.affiliatedAuthorKim, Mingyu-
dc.contributor.affiliatedAuthorLee, You Jeong-
dc.identifier.scopusid2-s2.0-85133560710-
dc.description.journalClass1-
dc.description.journalClass1-
dc.description.isOpenAccessY-
dc.type.docTypeArticle-
dc.subject.keywordPlusREGULATORY T-CELLS-
dc.subject.keywordPlusLOW-DOSE IL-2-
dc.subject.keywordPlusJAK INHIBITORS-
dc.subject.keywordPlusINTERLEUKIN-2-
dc.subject.keywordPlusIMMUNE-
dc.subject.keywordPlusSUBSETS-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordAuthoralopecia areata (AA)-
dc.subject.keywordAuthoranagen-
dc.subject.keywordAuthorhair-
dc.subject.keywordAuthorIL-2-
dc.subject.keywordAuthorTreg-
dc.relation.journalWebOfScienceCategoryImmunology-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-

qr_code

  • mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher

이유정LEE, YU JUNG
Dept of Life Sciences
Read more

Views & Downloads

Browse